Inhibition of brain protein kinase C attenuates immobilization stress-induced plasma corticosterone levels in mice

DH Kim, JS Jung, HS Kim, HW Suh, BK Son, YH Kim… - Neuroscience …, 2000 - Elsevier
DH Kim, JS Jung, HS Kim, HW Suh, BK Son, YH Kim, DK Song
Neuroscience letters, 2000Elsevier
To evaluate the involvement of brain protein kinase C (PKC) in the stress-induced activation
of hypothalamic-pituitary-adrenal (HPA) axis, we examined the effects of PKC inhibitors
administered intracerebroventricularly (icv) on the immobilization stress-induced plasma
corticosterone levels in mice. Calphostin C (a pan-specific PKC inhibitor) injected icv
decreased the immobilization stress-induced plasma corticosterone level: maximal inhibition
of 35% was attained at a dose of 100 pmol. Gö 6976 (an α and β1 PKC isotype-selective …
To evaluate the involvement of brain protein kinase C (PKC) in the stress-induced activation of hypothalamic-pituitary-adrenal (HPA) axis, we examined the effects of PKC inhibitors administered intracerebroventricularly (i.c.v.) on the immobilization stress-induced plasma corticosterone levels in mice. Calphostin C (a pan-specific PKC inhibitor) injected i.c.v. decreased the immobilization stress-induced plasma corticosterone level: maximal inhibition of 35% was attained at a dose of 100 pmol. Gö 6976 (an α and β1 PKC isotype-selective inhibitor) was less effective than Calphostin C: maximal inhibition of 17% was attained at a dose of 30 pmol. Phorbol 12-myristate 13-acetate (a general PKC activator) injected i.c.v. at doses of 16 and 48 pmol increased the plasma corticosterone levels in a dose-dependent manner. The present study demonstrates the involvement of PKC in the brain in the regulation of the immobilization stress-induced stimulation of HPA axis in vivo.
Elsevier